Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
5.98
-0.40 (-6.27%)
At close: May 17, 2024, 4:00 PM
6.05
+0.07 (1.17%)
After-hours: May 17, 2024, 7:39 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $470.90 million as of May 17, 2024. Its market cap has decreased by -58.04% in one year.
Market Cap
470.90M
Enterprise Value
-76.79M
1-Year Change
-58.04%
Ranking
Category
Stock Price
$5.98
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $470.90M, a decrease of -45.83%. That is a compound annual growth rate of -18.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 502.10M | -6.27% |
May 16, 2024 | 535.70M | 2.41% |
May 15, 2024 | 523.10M | - |
May 14, 2024 | 523.10M | 0.15% |
May 13, 2024 | 522.30M | 3.51% |
May 10, 2024 | 504.60M | -5.51% |
May 9, 2024 | 534.00M | 4.60% |
May 8, 2024 | 510.50M | -0.89% |
May 7, 2024 | 515.10M | -3.90% |
May 6, 2024 | 536.00M | - |
May 3, 2024 | 536.00M | 4.22% |
May 2, 2024 | 514.30M | 2.51% |
May 1, 2024 | 501.70M | -0.18% |
Apr 30, 2024 | 502.60M | -3.99% |
Apr 29, 2024 | 523.50M | 1.63% |
Apr 26, 2024 | 515.10M | -0.96% |
Apr 25, 2024 | 520.10M | -5.47% |
Apr 24, 2024 | 550.20M | -4.36% |
Apr 23, 2024 | 575.30M | -0.43% |
Apr 22, 2024 | 577.80M | 4.07% |
Apr 19, 2024 | 555.20M | -0.31% |
Apr 18, 2024 | 556.90M | -1.19% |
Apr 17, 2024 | 563.60M | -5.59% |
Apr 16, 2024 | 597.00M | -2.34% |
Apr 15, 2024 | 611.30M | -3.81% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Applied Therapeutics | 502.77M |
Larimar Therapeutics | 502.11M |
MaxCyte | 498.67M |
UroGen Pharma | 497.87M |
Editas Medicine | 493.43M |
Entrada Therapeutics | 489.17M |
Talkspace | 488.69M |
Nkarta | 484.82M |